Clinical & Pharma

As Costa Rican health officials monitor the nation's respiratory illness landscape, data from the Ministry of Health reveals a clear and pressing public health concern: Influenza A has firmly established itself as the most dominant circulating virus, outpacing both rhinovirus and COVID-19. In the

The loss of an adult tooth has long been considered a permanent event, a problem addressed only by synthetic replacements like dentures or implants that, while functional, are not a true biological restoration. However, a revolutionary wave of research emerging from Japan is challenging this

A recent comprehensive investigation by the Centers for Disease Control and Prevention (CDC) has brought a critical public health challenge into sharp focus, identifying extraintestinal invasive Escherichia coli as the foremost cause of sepsis that begins outside of a hospital setting. This

The American biomedical research landscape has emerged into 2026 bearing the deep and complex scars of a profoundly turbulent year, navigating a delicate balance between a renewed sense of financial security and a pervasive anxiety over the integrity of its foundational institutions. Following a

BioMarin Pharmaceutical is currently navigating a complex financial landscape as it prepares to release its financial results for the fourth quarter of 2025, presenting a puzzling scenario for the investment community. The prevailing consensus suggests a significant year-over-year decline in the

The complex health crises facing modern society, from pandemics to chronic diseases, increasingly demand solutions that transcend the traditional boundaries of scientific disciplines. Recognizing this critical shift, Texas A&M University recently convened the Life Sciences Graduate Recruitment